Sitemap
Pages
- Compare
- Custom Modification of Existing Neuroprotein
- Custom-Made Neuroproteins
- Discontinued
- DNA Damage
- Product availability notification
- Product Citations for Neurodegenerative Proteins
- Proteins for Neurodegenerative Disease Research
- Request a Quote | Custom Services | Neurodegenerative Proteins
- Technical Support Feedback
- Home – StressMarq
- Antibody Sample Program
- Support
- Technical Support Resources
- Contact Technical Support
- FAQs | Technical Support | All Products
- 100% Guarantee
- Protocols
- Protocols | AFM
- Protocols | Alpha Synuclein
- Protocols | Amyloid Beta
- Protocols | Sonication of PFFs
- Protocols | TEM
- Protocols | Dot Blot
- Protocols | Immunocytochemistry
- Protocols | Immunofluorescence
- Protocols | Immunohistochemistry
- Protocols | Immunoprecipitation
- Protocols | Tau
- Protocols | Western Blot
- Troubleshooting
- Safety Data Sheets
- Research Tools
- Technical Support Resources
- Company
- Blog
- Bulk Purchase Request
- Distributor Tools
- Ordering Information
- Primary Antibody Conjugates
- Promotions
- Shop
- Woocommerce Predictive Search
- International
- Privacy Policy
Posts
-
Announcements
- Holiday Office Hours 2024
- New Distributor in Taiwan: INTERLAB CO., LTD.
- Holiday Office Hours 2023
- StressMarq Biosciences & OrganoTherapeutics Begin New Collaboration
- New Distributor in India: OSB Agencies Private Ltd.
- StressMarq Awarded EcoVadis Medal
- New Distributor in Greece: P. Zafiropoulos S.A.
- New Distributor in Germany: 7BioScience
- Holiday Office Hours 2022
- Holiday Office Hours 2021
- New Distributor in Norway: XboXLab
- Holiday Office Hours 2020
- Cellectricon and StressMarq Biosciences Collaborate to Develop Next Generation Reagents and Assays to Advance Neurodegenerative Disease Research
- StressMarq COVID-19 Update
- New Distributor in the UK: 2B Scientific Ltd.
- 8th Annual Neuroscience Virtual Conference by Labroots
- New Distributor in Brazil: Start BioScience
- Review your StressMarq Antibody on pAbmAbs
- New Distributor in the USA: Eagle Biosciences Inc.
- New Distributor in Portugal and Spain: Deltaclon S.L.
- New Distributor in Mexico: Probiotek (Productos y Equipos Biotecnológicos S.A. de C.V.)
- New Distributor in China: Amyjet Scientific Inc.
- New Distributor in the USA: Biohippo
- Rewards for Reviews
- New Distributor in India: Everon Life Sciences
- New Distributor in the USA: ARP American Research Products, Inc.
- New Distributor in Hong Kong and Macau
- New Distributor in Singapore, Malaysia and Indonesia: Celestial Sphere Trading Pte. Ltd. (CST)
- New Distributor in Singapore and Malaysia: ProBioscience Technologies Pte. Ltd.
- Holiday Office Hours 2017
- Holiday Office Hours 2016
- New Distributor in Brazil: Uniscience Corporation
- New Website Launched
- Holiday Office Hours
- Happy Canada Day!
- LOKCO Technology: Distributor in Hong Kong and Macau
- Request: Looking for collaborators to help define types of oxidative stress
- New Distributor in Austria: Szabo-Scandic HandelsgmbH & Co KG
- New Distributor for Italy, Malta and Slovenia: Vinci-Biochem Srl
- Office Holiday Hours 2014
- New Distributor in Argentina: Diagnos Med srl
- Introducing the New Online HSP70 Scientific Resource Guide!
- Announcement: New StressMarq Logo
-
Conferences
-
New Products
-
Podcasts
-
Product Citation Reviews
- Irregular Cholesterol Metabolism Drives Neurodegeneration
- Reversing Tau Pathology Through Mitochondrial Regulation
- Regulating the Pathological Transmission of Alpha Synuclein
- Early Detection of Alzheimer’s Disease Using Imaging Probes
- Novel Vaccine Strategies for Parkinson’s Disease
- A Neuron/Astrocyte Model of Tau Pathology
- FABP2: A Novel Role in Gut Alpha Synuclein Pathology
- Microglial Activation in Alzheimer’s Disease
- C-Terminally Truncated Alpha Synuclein in Human Erythrocytes
- A Unique RNA-Binding Protein to Combat Tau Aggregation
- Chimeric Antigen Receptors in Alzheimer’s Disease Therapy
- Creating Reproducible Neurodegenerative Disease Models
- CDK14 Inhibition Decreases Alpha Synuclein Neurotoxicity
- ApoE4 Influences Astrocytic Tau Uptake & Clearance
- Alpha Synuclein and Mitochondrial Neurotoxicity
- Halting the Progression of Alzheimer’s Disease
- Utilizing Alpha Synuclein & Tau in the Development of Conformational Antibodies
- Gut Alpha Synuclein Aggregation in Parkinson’s Disease
- A Propagation Pathway for Mutant Alpha Synuclein Monomers
- Protein Aggregates as Early Biomarkers for Neurodegeneration
- The Role of VMP1 in Regulating NLRP3 Inflammasome Responses
- Defective Autophagy in Alzheimer’s Disease
- MOK protein kinase controls microglial response in Amyotrophic Lateral Sclerosis (ALS)
- Autoimmune Treatment using Extracellular Vesicles from Mesenchymal Stem Cells
- A Lysosomal Target for Treating Comorbidity in Neurodegenerative Diseases
- Cell Culture Media Influences Alpha Synuclein Aggregation
- Targeting Alpha Synuclein Aggregation in Early Parkinson’s Disease
- Bacterial Adaptation in Neonatal Meningitis
- Combating Neuroinflammation in Neurodegenerative Diseases
- Advancing Neuroscience with StressMarq Antibodies
- Mitophagy in Mitochondrial Diseases
- Exposing the Links Between Lysosomal Membrane Repair and Age-Related Diseases
- Uncovering the Role of Reelin in Parkinson’s Disease
- The Role of Molecular Chaperones in Neurodegenerative Diseases
- Therapeutic Approaches to Target Pathogenic Alpha-Synuclein
- Shining Light on the Cell-to-Cell Spread of Alpha-Synuclein
- Hsp70 and Alpha Synuclein Interaction in Synucleinopathies
- Lyme Disease infection may help trigger Lewy Body Dementia
- The Role of Cellular Senescence in the Pathogenesis of Parkinson’s Disease
- Targeting Alpha Synuclein Aggregation with CBP/p300 Inhibitors: A Novel Approach in Parkinson’s Disease Therapeutics
- Tau Induces Astrocyte Senescence in Alzheimer’s Disease
- How Polyamines Affect Tau Aggregation in Alzheimer’s Disease
- Study Reveals that a C-terminal Region of Metazoan Hsp110 Chaperones Provides a Novel Aggregation Prevention Mechanism
- The Neuroprotective Effects of Cornel Iridoid Glycoside in Alzheimer’s Disease
- Nuclear Tau and Lamins in Alzheimer’s Disease Progression
- Toxic Metals in E-cigarettes Lead to Oxidative DNA Damage
- The Epichaperome in Alzheimer’s Disease: The Effect of Stressors on Protein Networks
- The Epichaperome in Cancer Therapy: Using Protein Interaction Networks to Optimize Drug Delivery
- HSP40, YDJ1 Antibody Paper Review
- April-May 2015 Publications
- March 2015 Publications
- February 2015 Publications
- January 2015 Publications
- Heat Shock Protein 70 (HSP70) and Parasitic Infection
- 8-OH-dG, a Novel Immune Activator
- SIRT1, Cellular Stress and Metabolism
- HSP90 Inhibitors Could Lead to Selective Cancer Treatment
- HSP90 Inhibition Combined with HSF1-Targeted Treatments
- New Method for Combatting HIV?
- Resveratrol, Hsp27 and the Fight Against Breast Cancer
- Estrogen, Prolidase, and HIF-1alpha and their Effects in Breast Cancer
- Protein Homeostasis, the Heat Shock Response, and Cancer
- Hsp90 Plays Important Role in Male Fertility
- Deletion of Hsf1 in Mice Carrying Her2/Neu Significantly Reduces Breast Cancer and Metastasis
- Oxidative Stress and Alcohol-Induced Organ Dysfunction
- Ganetespib Effectiveness as an Hsp90 Inhibitor
-
Scientific Review
- Amyloid Beta Fibrillar Constructs
- Tau Fibrillar Constructs
- Alpha Synuclein Fibrillar Constructs
- Unraveling the Complexity of Tau Protein Isoforms
- The Pathogenesis of Multiple System Atrophy (MSA)
- Neurodegeneration and Climate Change
- Intercellular Transmission of Alpha Synuclein in Parkinson’s Disease and Other Synucleinopathies
- Uncovering Links Between Amyloid Beta and Alpha Synuclein in Neurodegenerative Diseases
- The Role of Amyloid Beta Oligomers in Alzheimer’s Disease
- Tau Oligomers in Alzheimer’s Disease
- Amyloid Hypothesis vs Tau Hypothesis
- Wild-Type Tau in Alzheimer’s Disease
- Akt Signaling, Cell Growth and Survival
- Oxidative DNA Damage and its Role in Disease
- The Role of Wild Type SOD1 in ALS
- Targeting Tau Monomers: Potential for Therapeutic Interventions
- Alpha Synuclein Monomers: Why Target Them?
- N-terminal Acetylated Alpha Synuclein in Parkinson’s Disease
- The Role of Rab1a in Cancer and Neurodegeneration
- DENND4C and the Retromer Complex in Neurodegenerative Diseases
- Tau in Alzheimer’s Disease Therapeutics
- Tau in Alzheimer’s Disease Diagnostics
- How Does Sonication Affect Alpha Synuclein Preformed Fibrils?
- Parkinson’s Disease Therapies Targeting Alpha Synuclein
- Alpha Synuclein in Parkinson’s Disease Diagnostics
- Types of Tau Fibrillar Constructs
- Types of Alpha Synuclein Fibrillar Constructs
- EGCG Alpha Synuclein Oligomers
- Alpha Synuclein Oligomers and their Role in Synucleinopathies
- How to Write a Scientific Paper
- FTY720/Fingolimod: A Potential Parkinson’s Disease Treatment
- Tau Post-Translational Modifications: An Overview of the Baculovirus Expression Vector System
- Tau Post-Translational Modifications in Alzheimer’s Disease: Diagnostic and Therapeutic Opportunities
- Transthyretin Amyloid Fibrils in Amyloidosis Research
- Tau Mutations and their Association with Neurodegenerative Disease
- Alpha Synuclein Phosphorylation at Serine 129
- Camostat Mesylate: A Potential COVID-19 Treatment
- Modelling Alzheimer’s Disease in Cells and Animals
- The Pathophysiology of Alzheimer’s Disease
- Parkinson’s Disease Models: An Overview of Cellular and Animal Models for Neurodegeneration Research
- Alpha Synuclein in Parkinson’s Disease
- Tau Protein and its Role in Alzheimer’s Disease
- Sonication of Pre-formed Fibrils in Neurodegeneration Research
- VPS35 in Parkinson’s Disease
- Alpha Synuclein and Tau Interactions in Neurodegenerative Diseases
- Tau Phosphorylation in Alzheimer’s Disease
- Alpha Synuclein Oligomers: Dopamine Stabilization and Neurodegeneration
- Transthyretin (TTR) In Amyloid Diseases
- SOD1 Aggregation in Amyloid Lateral Sclerosis (ALS)
- Gamma Synuclein Aggregation in Neurodegenerative Diseases
- PCT Patent Application: Monoclonal Antibody Targets Alpha Synuclein and Tau Aggregation
- A53T Alpha Synuclein in Parkinson’s Disease
- Tau Aggregation and Alzheimer’s
- Insulin Resistance in the Brain – Mode of Action in Alzheimer’s Disease?
- Co-Chaperones in Ubiquitin Degradation Pathway
- Role of AXL in Fight against Cancer
- Inflammatory Effects of Alcohol in Neuronal Cells
- Co-Chaperone Hsp27: Key Factor in Prostate Cancer
- The Role of Bag5 in Prostate Cancer and Apoptosis
- Metformin: a Panacea for Diabetes, Cancer and Aging?
-
Stress Reducers
- New Antibody Citation System
- 7 Resources for Free Science Pictures
- Western Blot Troubleshooting: 8 Western Blot Protocol Issues Solved
- Immunohistochemistry vs Immunocytochemistry
- How to Cite a Product
- How to Make a Scientific Poster
- Proper Reagent Storage and Handling
- 15 Science Pick-Up Lines
- Polyclonal vs Monoclonal Antibodies
- 5 Free Image Analysis Software Tools for Microscopy
- 5 Reasons Why Working Over the Holiday Isn’t So Bad
- 6 Quick Ways to Get Your Research Project Holiday Ready
- Top 10 Neuroscience Jokes
- What does that look like under a microscope? – Beverage Edition
- Get Ready for a Partial Solar Eclipse – Oct. 23rd, 2014
- International Space Station High-Def Earth Viewing Experiment
- Science to the Rescue: Eye-Popping Images for Weary Travellers
-
This Day in Science
- This Day in Science Dec. 8, 1994 – Unununium (Element 111) Created
- This Day In Science Dec. 2, 1982 – First Artificial Heart Transplant
- This Day in Science Nov. 24, 1859 – Origin of Species Published
- This Day In Science Nov. 20, 1979 – First Artificial Blood Transfusion
- This Day In Science Nov. 9, 1989 – Fall of the Berlin Wall
- This Day In Science Sept. 24, 1855 – Glycogen Discovered
- This Day In Science Sept. 17, 1953 – Conjoined Twins Separated Successfully
- This Day In Science Sept. 16, 1987 – Ozone Protection Protocol Ratified
- This Day In Science Sept. 7, 1888 – First Baby Incubator
- This Day In Science Aug. 27, 1875 – Gallium Discovered
- This Day In Science Aug. 18, 1960 – First Oral Contraceptive
- This Day In Science Aug. 25, 1973 – First CAT Scan
- This Day in Science June 26, 2000 – First DNA Sequence from Human Genome Project
- This Day in Science June 25, 1924 – First Tuberculosis Vaccine
- This Day In Science June 17, 1950 – First Successful Kidney Transplant
- This Day In Science June 5, 1981 – AIDS First Described
- This Day In Science May 28, 2003 – First Cloned Horse
- This Day In Science May 26, 1676 – Bacteria Discovered
- This Day In Science May 20, 1875 – Treaty of the Meter Signed
- This Day In Science May 14, 1796 – First Vaccine Administered
-
Video
-
Webinar